Position in AZN
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$3,976,349
New position
Shares Held
20,162
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 97%
Shared 0%
None 3%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026EXENCIAL WEALTH ADVISORS, LLC holds $76,718,350 across 13 Drug Manufacturers - General names. AZN ranks #6 (5.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVS |
Novartis AG
|
108,594 | $16,587,733 | |
| 2 | LLY |
ELI LILLY & Co
|
17,141 | $15,765,777 | |
| 3 | JNJ |
Johnson & Johnson
|
41,920 | $10,246,924 | |
| 4 | ABBV |
AbbVie Inc.
|
41,150 | $8,949,713 | |
| 5 | AMGN |
Amgen Inc
|
17,401 | $6,122,541 | |
| 6 | AZN |
Astrazeneca PLC
This page
|
20,162 | $3,976,349 | |
| 7 | SNY |
Sanofi
|
81,382 | $3,920,984 | |
| 8 | GSK |
GSK plc
|
55,198 | $3,046,377 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,976,349 | 20,162 | Shares | Sole | 2026-04-28 | |
| No filing history on record for this holder in this stock. | ||||||